Krystal Biotech (KRYS) Net Cash Flow Growth (3y) (2019 - 2026)
Krystal Biotech (KRYS) Net Cash Flow Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -50.33% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.47% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 33.37% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -29.82% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn | 32.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.00% |
| Dec 31, 2025 | 84.34% |
| Sep 30, 2025 | 47.51% |
| Jun 30, 2025 | 42.11% |
| Mar 31, 2025 | 20.41% |
| Dec 31, 2024 | -36.11% |
| Sep 30, 2024 | 38.38% |
| Jun 30, 2024 | 43.82% |
| Mar 31, 2024 | -84.58% |
| Dec 31, 2023 | -1.57% |
| Sep 30, 2023 | 131.82% |
| Jun 30, 2023 | 6.63% |
| Mar 31, 2023 | -42.56% |
| Dec 31, 2022 | -49.71% |
| Sep 30, 2022 | -81.02% |
| Jun 30, 2022 | -37.00% |
| Mar 31, 2022 | -133.42% |
| Dec 31, 2021 | -1.41% |
| Sep 30, 2021 | -121.32% |
| Jun 30, 2021 | -255.71% |